Targeting one type of immune cell with another slows cancer growth in preclinical studies

A new approach to cancer immunotherapy that uses one type of immune cell to kill another -- rather than directly attacking the cancer -- provokes a robust anti-tumor immune response that shrinks ovarian, lung, and pancreatic tumors in preclinical disease models, according to researchers. The study involved a twist on a type of therapy that uses immune cells known as CAR T cells.

from Top Health News -- ScienceDaily https://ift.tt/iqwOmL6